Skip to Main Content

HUJI logo Hebrew
The Library Authority    רשות הספריות

Library Research Guides    מדריכים לפי תחומים

Hadassah Medical Center: Mevorach Dror

Last updated September 2023 - Hadassah Medical Center

List of Publications

 

  1. Kenig, A., Nachman, D., Aliev, E., Wagnert-Avraham, L., Kolben, Y., Kessler, A., Lutsker, M., & Mevorach, D. (2024). Apoptotic Cell-Based Therapy for the Modification of the Inflammatory Response to Hemorrhagic Shock. Military Medicine, 189, 416–422. https://doi.org/10.1093/milmed/usae143
  2. Aharon, A., Benedek, G., Barhoum, B., Parnasa, E., Magadle, N., Perzon, O., & Mevorach, D. (2024). HLA binding-groove motifs are associated with myocarditis induction after Pfizer-BioNTech BNT162b2 vaccination. European Journal of Clinical Investigation, 54(4). https://doi.org/10.1111/eci.14142
  3. Ankri, C., Hershkovitz, O., Hershkovitz, L., Brami, M., Levy, R., Sarig, H., Souli, E., Reicher, B., Amor-Baroukh, V., Mevorach, D., & Nyska, A. (2024). Safety of Repeated Administration of Xenogeneic Human Apoptotic State (Allocetra-OTS) in Sprague Dawley Rats. Pharmaceutics, 16(3). https://doi.org/10.3390/pharmaceutics16030426
  4. Canavati, C., Siam, A., Labes, S., Trabelsi, N., Regev, E., Parnasa, E., Barhoum, B., Magadle, N., Perzon, O., Braun, M., Mor-Shaked, H., Schueler-Furman, O., Tabach, Y., & Mevorach, D. (2024). Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19). Circulation, 149(3), 270–273. https://doi.org/10.1161/CIRCULATIONAHA.123.064884
  5. Karbian, N., Eshed-Eisenbach, Y., Zeibak, M., Tabib, A., Sukhanov, N., Vainshtein, A., Morgan, B. P., Fellig, Y., Peles, E., & Mevorach, D. (2023). Complement-membrane regulatory proteins are absent from the nodes of Ranvier in the peripheral nervous system. Journal of Neuroinflammation, 20(1). https://doi.org/10.1186/s12974-023-02920-9
  6. van Heerden, P. V, Abutbul, A., Naama, A., Maayan, S., Makram, N., Nachshon, A., abu Jabal, K., Hershkovitz, O., Binder, L., Shabat, Y., Reicher, B., & Mevorach, D. (2023). Apoptotic cells for treatment of acute respiratory distress syndrome associated with COVID-19. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1242551
  7. Kharouf, F., Eviatar, T., Braun, M., Pokroy-Shapira, E., Brodavka, M., Zloof, Y., Agmon-Levin, N., Toledano, K., Oren, S., Lidar, M., Zisman, D., Tavor, Y., Amit-Vazina, M., Sabbah, F., Breuer, G. S., Dagan, A., Beshara-Garzuzi, R., Markovits, D., Elias, M., … Braun-Moscovici, Y. (2023). A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinations. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1064839
  8. Perzon, O., Kenig, A., Fellig, Y., & Mevorach, D. (2022). Use of Colchicine for Pericardial Inflammation: Risks and Toxicities—A Cautionary Tale. JACC: Case Reports, 4(21), 1449–1452. https://doi.org/10.1016/j.jaccas.2022.08.027
  9. Thurner, L., Kessel, C., Fadle, N., Regitz, E., Seidel, F., Kindermann, I., Lohse, S., Kos, I., Tschöpe, C., Kheiroddin, P., Kiblboeck, D., Hoffmann, M.-C., Bette, B., Carbon, G., Cetin, O., Preuss, K.-D., Christofyllakis, K., Bittenbring, J. T., Pickardt, T., … Klingel, K. (2022). IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination. New England Journal of Medicine, 387(16), 1524–1527. https://doi.org/10.1056/NEJMc2205667
  10. Mevorach, D., Anis, E., Cedar, N., Hasin, T., Bromberg, M., Goldberg, L., Levi, N., Perzon, O., Magadle, N., Barhoum, B., Parnassa, E., Dichtiar, R., Hershkovitz, Y., Green, M. S., Ash, N., Keinan-Boker, L., & Alroy-Preis, S. (2022). Myocarditis After BNT162b2 COVID-19 Third Booster Vaccine in Israel. Circulation, 146(10), 802–804. https://doi.org/10.1161/CIRCULATIONAHA.122.060961
  11. Mevorach, D., Anis, E., Cedar, N., Hasin, T., Bromberg, M., Goldberg, L., Parnasa, E., Dichtiar, R., Hershkovitz, Y., Ash, N., Green, M. S., Keinan-Boker, L., & Alroy-Preis, S. (2022). Myocarditis after BNT162b2 Vaccination in Israeli Adolescents. New England Journal of Medicine, 386(10), 998–999. https://doi.org/10.1056/NEJMc2116999
  12. Horwitz, E., Perzon, O., & Mevorach, D. (2022). Therapeutic options in COVID-19. In Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination (pp. 647–672). Elsevier. https://doi.org/10.1016/B978-0-443-18566-3.00034-7
  13. Mevorach, D. (2022). Myocarditis following vaccination with Pfizer-BioNTech BNT162b2 against coronavirus infection (COVID-19). In Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination (pp. 427–436). Elsevier. https://doi.org/10.1016/B978-0-443-18566-3.00019-0
  14. Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E., Olsha-Castell, S., Arad, D., Hasin, T., Levi, N., Asleh, R., Amir, O., Meir, K., Cohen, D., Dichtiar, R., Novick, D., Hershkovitz, Y., Dagan, R., Leitersdorf, I., … Alroy-Preis, S. (2021). Myocarditis after BNT162b2 mRNA vaccine against covid-19 in Israel. New England Journal of Medicine, 385(23), 2140–2149. https://doi.org/10.1056/NEJMoa2109730
  15. Butbul Aviel, Y., Ofir, A., Ben-Izhak, O., Vlodavsky, E., Karbian, N., Brik, R., Mevorach, D., & Magen, D. (2021). A novel loss-of-function mutation in LACC1 underlies hereditary juvenile arthritis with extended intra-familial phenotypic heterogeneity. Rheumatology (United Kingdom), 60(10), 4888–4898. https://doi.org/10.1093/rheumatology/keab017
  16. van Heerden, P. V, Abutbul, A., Sviri, S., Zlotnick, E., Nama, A., Zimro, S., el-Amore, R., Shabat, Y., Reicher, B., Falah, B., & Mevorach, D. (2021). Apoptotic Cells for Therapeutic Use in Cytokine Storm Associated With Sepsis– A Phase Ib Clinical Trial. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.718191
  17. Elias, S., Kol, I., Kahlon, S., Amore, R., Zeibak, M., Mevorach, D., Elchalal, U., Zelig, O., & Mandelboim, O. (2021). Anti-RhD antibody therapy modulates human natural killer cell function. Haematologica, 106(7), 1846–1856. https://doi.org/10.3324/haematol.2019.238097
  18. Danylesko, I., Shouval, R., Shem-Tov, N., Yerushalmi, R., Jacoby, E., Besser, M. J., Shimoni, A., Davidson, T., Beider, K., Mevorach, D., Fried, S., Nagler, A., & Avigdor, A. (2021). Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphoma. Bone Marrow Transplantation, 56(5), 1134–1143. https://doi.org/10.1038/s41409-020-01156-y
  19. Ben-Eli, H., Solomon, A., Aframian, D. J., Ben-Chetrit, E., Mevorach, D., Kleinstern, G., Waterboer, T., Willhauck-Fleckenstein, M., Pawlita, M., & Paltiel, O. (2020). Serological and hematological characteristics of Sjogren’s syndrome and dry eye syndrome patients using a novel immune serology technique. PLoS ONE, 15(12 December). https://doi.org/10.1371/journal.pone.0244712
  20. Perles, Z., Ishay, Y., Nir, A., Gavri, S., Golender, J., Ta-Shma, A., Abu-Zahira, I., Natsheh, J., Elchalal, U., Mevorach, D., & Rein, A. J. J. T. (2020). Immune-mediated fetal complete atrioventricular block: Can dexamethasone therapy revert the process? Israel Medical Association Journal, 22(11), 711–716. https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097037586&partnerID=40&md5=dd84ea84ab9578d449c0441a5df21e8a
  21. Langevitz, P., Lidar, M., Rosner, I., Feld, J., Tishler, M., Amital, H., Aamar, S., Elkayam, O., Balbir-Gurman, A., Abu-Shakra, M., Mevorach, D., Kimhi, O., Molad, Y., Kuperman, A., & Ehrlich, S. (2020). A Study of the Efficacy and Safety of Subcutaneous Injections of Tocilizumab in Adults with Rheumatoid Arthritis. The Israel Medical Association Journal : IMAJ, 22(9), 557–563. https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096816592&partnerID=40&md5=eba0795c2d497c659cb50ab23848f378
  22. Langevitz, P., Lidar, M., Rosner, I., Feld, J., Tishler, M., Amital, H., Aamar, S., Elkayam, O., Balbir-Gurman, A., Abu-Shakra, M., Mevorach, D., Kimhi, O., Molad, Y., Kuperman, A., & Ehrlich, S. (2020). A study of the efficacy and safety of subcutaneous injections of tocilizumab in adults with rheumatoid arthritis. Israel Medical Association Journal, 22(9), 491–497. https://www.scopus.com/inward/record.uri?eid=2-s2.0-85091265168&partnerID=40&md5=04726992cd6abbe26388fa3d7ceb7742
  23. Karbian, N., Abutbul, A., el-Amore, R., Eliaz, R., Beeri, R., Reicher, B., & Mevorach, D. (2020). Apoptotic cell therapy for cytokine storm associated with acute severe sepsis. Cell Death and Disease, 11(7). https://doi.org/10.1038/s41419-020-02748-8
  24. Segal, G., Mevorach, D., Elis, A., & Dicker, D. (2020). Clinical insights and management recommendations for COVID-19 patients hospitalized in internal medicine departments: Recommendations by the corona department heads in Israel. Israel Medical Association Journal, 22(5), 275–277. https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084327808&partnerID=40&md5=f973097a16230fdc218604a8eb69ef81
  25. Shamriz, O., Tal, Y., Durst, R., Pollak, A., Moses, A. E., & Mevorach, D. (2019). Early onset, non-rheumatic, group A streptococcal-associated myocarditis. Clinical and Experimental Rheumatology, 37(4), 546–551. https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069267214&partnerID=40&md5=59fca1a8c08bb34c642481c681dabfdf
  26. Ben-Eli, H., Gomel, N., Aframian, D. J., Abu-Seir, R., Perlman, R., Ben-Chetrit, E., Mevorach, D., Kleinstern, G., Paltiel, O., & Solomon, A. (2019). SNP variations in IL10, TNFα and TNFAIP3 genes in patients with dry eye syndrome and Sjogren’s syndrome. Journal of Inflammation (United Kingdom), 16(1). https://doi.org/10.1186/s12950-019-0209-z
  27. Kurolap, A., Eshach Adiv, O., Hershkovitz, T., Tabib, A., Karbian, N., Paperna, T., Mory, A., Vachyan, A., Slijper, N., Steinberg, R., Zohar, Y., Mevorach, D., & Baris Feldman, H. (2019). Eculizumab is safe and effective as a long-Term treatment for protein-losing enteropathy due to cd55 deficiency. Journal of Pediatric Gastroenterology and Nutrition, 68(3), 325–333. https://doi.org/10.1097/MPG.0000000000002198
  28. Ben-Eli, H., Aframian, D. J., Ben-Chetrit, E., Mevorach, D., Kleinstern, G., Paltiel, O., & Solomon, A. (2019). Shared medical and environmental risk factors in dry eye syndrome, Sjogren’s syndrome, and B-cell non-Hodgkin lymphoma: A case-control study. Journal of Immunology Research, 2019. https://doi.org/10.1155/2019/9060842
  29. Karbian, N., Eshed-Eisenbach, Y., Tabib, A., Hoizman, H., Paul Morgan, B., Schueler-Furman, O., Peles, E., & Mevorach, D. (2018). Molecular pathogenesis of human CD59 deficiency. Neurology: Genetics, 4(6). https://doi.org/10.1212/NXG.0000000000000280
  30. Tabib, A., Hindi, I., Karbian, N., Zelig, O., Falach, B., & Mevorach, D. (2018). Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59. Thrombosis Research, 168, 67–77. https://doi.org/10.1016/j.thromres.2018.06.006
  31. Trahtemberg, U., & Mevorach, D. (2017). Apoptotic cells induced signaling for immune homeostasis in macrophages and dendritic cells. Frontiers in Immunology, 8(OCT). https://doi.org/10.3389/fimmu.2017.01356
  32. Tabib, A., Karbian, N., & Mevorach, D. (2017). Demyelination, strokes, and eculizumab: Lessons from the congenital CD59 gene mutations. Molecular Immunology, 89, 69–72. https://doi.org/10.1016/j.molimm.2017.05.024
  33. Fleischmann, R., Mysler, E., Hall, S., Kivitz, A. J., Moots, R. J., Luo, Z., DeMasi, R., Soma, K., Zhang, R., Takiya, L., Tatulych, S., Mojcik, C., Krishnaswami, S., Menon, S., Smolen, J. S., Adams, L., Ally, M. M., du Plooy, M. C., Louw, I. C., … Pena, R. (2017). Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial. The Lancet, 390(10093), 457–468. https://doi.org/10.1016/S0140-6736(17)31618-5
  34. Kurolap, A., Eshach-Adiv, O., Hershkovitz, T., Paperna, T., Mory, A., Oz-Levi, D., Zohar, Y., Mandel, H., Chezar, J., Azoulay, D., Peleg, S., Half, E. E., Yahalom, V., Finkel, L., Weissbrod, O., Geiger, D., Tabib, A., Shaoul, R., Magen, D., … Baris, H. N. (2017). Loss of CD55 in eculizumab-responsive protein-losing enteropathy. New England Journal of Medicine, 377(1), 87–89. https://doi.org/10.1056/NEJMc1707173
  35. Clowse, M. E. B., Wallace, D. J., Furie, R. A., Petri, M. A., Pike, M. C., Leszczyński, P., Neuwelt, C. M., Hobbs, K., Keiserman, M., Duca, L., Kalunian, K. C., Galateanu, C., Bongardt, S., Stach, C., Beaudot, C., Kilgallen, B., Gordon, C., Batalov, A., Bojinca, M., … Group, the E. I. (2017). Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials. Arthritis and Rheumatology, 69(2), 362–375. https://doi.org/10.1002/art.39856
  36. Mevorach, D., Reiner, I., Grau, A., Ilan, U., Berkun, Y., Ta-Shma, A., Elpeleg, O., Shorer, Z., Edvardson, S., & Tabib, A. (2016). Therapy with eculizumab for patients with CD59 p.Cys89Tyr mutation. Annals of Neurology, 80(5), 708–717. https://doi.org/10.1002/ana.24770
  37. Reis, S., Urkin, J., Nave, R., Ber, R., Ziv, A., Karnieli-Miller, O., Meitar, D., Gilbey, P., & Mevorach, D. (2016). Medical education in Israel 2016: Five medical schools in a period of transition. Israel Journal of Health Policy Research, 5(1). https://doi.org/10.1186/s13584-016-0104-5
  38. Trahtemberg, U., Grau, A., Tabib, A., Atallah, M., Krispin, A., & Mevorach, D. (2016). Identification and characterization of two human monocyte-derived dendritic cell subpopulations with different functions in dying cell clearance and different patterns of cell death. PLoS ONE, 11(9). https://doi.org/10.1371/journal.pone.0162984
  39. Mevorach, D. (2015). Paroxysmal nocturnal hemoglobinuria (PNH) and primary p.Cys89Tyr mutation in CD59: Differences and similarities. Molecular Immunology, 67(1), 51–55. https://doi.org/10.1016/j.molimm.2015.03.005
  40. Hanna, J., Gonen-Gross, T., Fitchett, J., Rowe, T., Daniels, M., Arnon, T. I., Gazit, R., Joseph, A., Schjetne, K. W., Steinle, A., Porgador, A., Mevorach, D., Goldman-Wohl, D., Yagel, S., LaBarre, M. J., Buckner, J. H., & Mandelboim, O. (2015). Erratum: Novel APC-like properties of human NK cells directly regulate T cell activation (Journal of Clinical Investigation (2015) 125:4 (1763)). Journal of Clinical Investigation, 125(4), 1763. https://doi.org/10.1172/JCI81527
  41. Grau, A., Tabib, A., Grau, I., Reiner, I., & Mevorach, D. (2015). Apoptotic cells induce NF-κB and inflammasome negative signaling. PLoS ONE, 10(3). https://doi.org/10.1371/journal.pone.0122440
  42. Szalat, A., Shahar, M., Shpitzen, S., Nachmias, B., Munter, G., Gillis, D., Durst, R., Mevorach, D., Leitersdorf, E., Meiner, V., & Rosen, H. (2015). Calcium-sensing receptor sequencing in 21 patients with idiopathic or familial parathyroid disorder: pitfalls and characterization of a novel I32 V loss-of-function mutation. Endocrine, 48(2), 444–453. https://doi.org/10.1007/s12020-014-0370-3
  43. Gur, C., Ibrahim, Y., Isaacson, B., Yamin, R., Abed, J., Gamliel, M., Enk, J., Bar-On, Y., Stanietsky-Kaynan, N., Coppenhagen-Glazer, S., Shussman, N., Almogy, G., Cuapio, A., Hofer, E., Mevorach, D., Tabib, A., Ortenberg, R., Markel, G., Miklić, K., … Mandelboim, O. (2015). Binding of the Fap2 protein of fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity, 42(2), 344–355. https://doi.org/10.1016/j.immuni.2015.01.010
  44. Ben-Zeev, B., Tabib, A., Nissenkorn, A., Garti, B.-Z., Gomori, J. M., Nass, D., Goldshmidt, H., Fellig, Y., Anikster, Y., Nevo, Y., Elpeleg, O., & Mevorach, D. (2015). Devastating recurrent brain ischemic infarctions and retinal disease in pediatric patients with CD59 deficiency. European Journal of Paediatric Neurology, 19(6), 688–693. https://doi.org/10.1016/j.ejpn.2015.07.001
  45. Mevorach, D., Zuckerman, T., Reiner, I., Shimoni, A., Samuel, S., Nagler, A., Rowe, J. M., & Or, R. (2014). Single Infusion of Donor Mononuclear Early Apoptotic Cells as Prophylaxis for Graft-versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantation: A Phase I/IIa Clinical Trial. Biology of Blood and Marrow Transplantation, 20(1), 58–65. https://doi.org/10.1016/j.bbmt.2013.10.010
  46. Gur, C., Coppenhagen-Glazer, S., Rosenberg, S., Yamin, R., Enk, J., Glasner, A., Bar-On, Y., Fleissig, O., Naor, R., Abed, J., Mevorach, D., Granot, Z., Bachrach, G., & Mandelboim, O. (2013). Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells. Cell Host and Microbe, 14(6), 664–674. https://doi.org/10.1016/j.chom.2013.11.004
  47. Stepensky, P., Simanovsky, N., Averbuch, D., Gross, M., Yanir, A., Mevorach, D., Elpeleg, O., & Weintraub, M. (2013). VPS 45-associated primary infantile myelofibrosis - Successful treatment with hematopoietic stem cell transplantation. Pediatric Transplantation, 17(8), 820–825. https://doi.org/10.1111/petr.12169
  48. Stepensky, P., Saada, A., Cowan, M., Tabib, A., Fischer, U., Berkun, Y., Saleh, H., Simanovsky, N., Kogot-Levin, A., Weintraub, M., Ganaiem, H., Shaag, A., Zenvirt, S., Borkhardt, A., Elpeleg, O., Bryant, N. J., & Mevorach, D. (2013). The Thr224Asn mutation in the VPS45 gene is associated with the congenital neutropenia and primary myelofibrosis of infancy. Blood, 121(25), 5078–5087. https://doi.org/10.1182/blood-2012-12-475566
  49. Nevo, Y., Ben-Zeev, B., Tabib, A., Straussberg, R., Anikster, Y., Shorer, Z., Fattal-Valevski, A., Ta-Shma, A., Aharoni, S., Rabie, M., Zenvirt, S., Goldshmidt, H., Fellig, Y., Shaag, A., Mevorach, D., & Elpeleg, O. (2013). CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy. Blood, 121(1), 129–135. https://doi.org/10.1182/blood-2012-07-441857
  50. Ablin, J. N., Amital, H., Ehrenfeld, M., Aloush, V., Elkayam, O., Langevitz, P., Mevorach, D., Mader, R., Sachar, T., Amital, D., Buskila, D., & Association, I. R. (2013). [Guidelines for the diagnosis and treatment of the fibromyalgia syndrome]. Harefuah, 152(12), 742-747,750,751. https://www.scopus.com/inward/record.uri?eid=2-s2.0-84893797861&partnerID=40&md5=245f07eed6a716f6bb8dc814819727fc
  51. Scheiman Elazary, A., Cohen, M. J., Aamar, S., Dranitzki, Z., Tayer-Shifman, O., Mevorach, D., Ben-Chetrit, E., & Naparstek, Y. (2012). Pulmonary hemorrhage in antiphospholipid antibody syndrome. Journal of Rheumatology, 39(8), 1628–1631. https://doi.org/10.3899/jrheum.120205
  52. Benhamron, S., Reiner, I., Zcharia, E., Atallah, M., Grau, A., Vlodavsky, I., & Mevorach, D. (2012). Dissociation between mature phenotype and impaired transmigration in dendritic cells from heparanase-deficient mice. PLoS ONE, 7(5). https://doi.org/10.1371/journal.pone.0035602
  53. Zimran, E., Shilo, S., Florescu, T., Dotan, S., Balag, S., Mevorach, D., Shibolet, O., & Amer, R. (2012). Paradoxical response in ocular bartonellosis. Journal of Ophthalmic Inflammation and Infection, 2(1), 53–56. https://doi.org/10.1007/s12348-011-0046-6
  54. Atallah, M., Krispin, A., Trahtemberg, U., Ben-Hamron, S., Grau, A., Verbovetski, I., & Mevorach, D. (2012). Constitutive neutrophil apoptosis: Regulation by cell concentration via S100 A8/9 and the MEK - ERK pathway. PLoS ONE, 7(2). https://doi.org/10.1371/journal.pone.0029333
  55. Ergaz, Z., Mevorach, D., Goldzweig, G., Cohen, A., Patlas, N., Yaffe, P., Blank, M., Shoenfeld, Y., & Ornoy, A. (2010). The embryotoxicity of sera from patients with autoimmune diseases on post-implantation rat embryos in culture persists during remission and is not related to oxidative stress. Lupus, 19(14), 1623–1631. https://doi.org/10.1177/0961203310377218
  56. Mevorach, D. (2010). Clearance of dying cells and systemic lupus erythematosus: The role of C1q and the complement system. Apoptosis, 15(9), 1114–1123. https://doi.org/10.1007/s10495-010-0530-8
  57. Fattal, I., Shental, N., Mevorach, D., Anaya, J.-M., Livneh, A., Langevitz, P., Zandman-Goddard, G., Pauzner, R., Lerner, M., Blank, M., Hincapie, M.-E., Gafter, U., Naparstek, Y., Shoenfeld, Y., Domany, E., & Cohen, I. R. (2010). An antibody profile of systemic lupus erythematosus detected by antigen microarray. Immunology, 130(3), 337–343. https://doi.org/10.1111/j.1365-2567.2010.03245.x
  58. Amarilyo, G., Verbovetski, I., Atallah, M., Grau, A., Wiser, G., Gil, O., Ben-Neriah, Y., & Mevorach, D. (2010). iC3b-opsonized apoptotic cells mediate a distinct anti-inflammatory response and transcriptional NF-κB-dependent blockade. European Journal of Immunology, 40(3), 699–709. https://doi.org/10.1002/eji.200838951
  59. Mevorach, D., Trahtemberg, U., Krispin, A., Attalah, M., Zazoun, J., Tabib, A., Grau, A., & Verbovetski-Reiner, I. (2010). What do we mean when we write “senescence,”"apoptosis,""necrosis," or “clearance of dying cells”? In Annals of the New York Academy of Sciences (Vol. 1209, Issue 1, pp. 1–9). Blackwell Publishing Inc. https://doi.org/10.1111/j.1749-6632.2010.05774.x
  60. Tabib, A., Krispin, A., & Mevorach, D. (2010). Role of class A human thrombospondins in the clearance of dying cells and tolerance induction. In Annals of the New York Academy of Sciences (Vol. 1209, Issue 1, pp. 43–48). Blackwell Publishing Inc. https://doi.org/10.1111/j.1749-6632.2010.05773.x
  61. Trahtemberg, U., & Mevorach, D. (2009). Methods used to study apoptotic cell clearance. In Phagocytosis of Dying Cells: From Molecular Mechanisms to Human Diseases (pp. 217–268). Springer Netherlands. https://doi.org/10.1007/978-1-4020-9293-0_8
  62. Mevorach, D. (2009). Clearance of dying cells and systemic lupus erythematosus. In Phagocytosis of Dying Cells: From Molecular Mechanisms to Human Diseases (pp. 299–318). Springer Netherlands. https://doi.org/10.1007/978-1-4020-9293-0_10
  63. Rein, A. J. J. T., Perles, Z., Gavri, S., Nir, A., Mevorach, D., Nadjari, M., & Elchalal, U. (2009). Response to letter regarding article, “early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/ Ro-SSB/La antibodies: A prospective, observational, fetal kinetocardiogram-based study.” Circulation, 120(21). https://doi.org/10.1161/CIRCULATIONAHA.109.886515
  64. Mevorach, D., Elchalal, U., & Rein, A. J. J. T. (2009). Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: Detection and treatment of first-degree atrioventricular block. Current Opinion in Rheumatology, 21(5), 478–482. https://doi.org/10.1097/BOR.0b013e32832ed817
  65. Tabib, A., Krispin, A., Trahtemberg, U., Verbovetski, I., Lebendiker, M., Danieli, T., & Mevorach, D. (2009). Thrombospondin-1-N-terminal domain induces a phagocytic state and thrombospondin-1-C-terminal domain induces a tolerizing phenotype in dendritic cells. PLoS ONE, 4(8). https://doi.org/10.1371/journal.pone.0006840
  66. Rein, A. J. J. T., Mevorach, D., Perles, Z., Gavri, S., Nadjari, M., Nir, A., & Elchalal, U. (2009). Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies a prospective, observational, fetal kinetocardiogram-based study. Circulation, 119(14), 1867–1872. https://doi.org/10.1161/CIRCULATIONAHA.108.773143
  67. Berkun, Y., Verbovetski, I., Ben-Ami, A., Paran, D., Caspi, D., Krispin, A., Trahtemberg, U., Gill, O., Naparstek, Y., & Mevorach, D. (2008). Altered dendritic cells with tolerizing phenotype in patients with systemic lupus erythematosus. European Journal of Immunology, 38(10), 2896–2904. https://doi.org/10.1002/eji.200838342
  68. Hershko, A. Y., Berkun, Y., Mevorach, D., Rubinow, A., & Naparstek, Y. (2008). Increased Intracranial Pressure Related to Systemic Lupus Erythematosus: A 26-year Experience. Seminars in Arthritis and Rheumatism, 38(2), 110–115. https://doi.org/10.1016/j.semarthrit.2007.09.007
  69. Trahtemberg, U., Atallah, M., Krispin, A., Verbovetski, I., & Mevorach, D. (2007). Calcium, leukocyte cell death and the use of annexin V: Fatal encounters. Apoptosis, 12(10), 1769–1780. https://doi.org/10.1007/s10495-007-0097-1
  70. Zaguri, R., Verbovetski, I., Atallah, M., Trahtemberg, U., Krispin, A., Nahari, E., Leitersdorf, E., & Mevorach, D. (2007). “Danger” effect of low-density lipoprotein (LDL) and oxidized LDL on human immature dendritic cells. Clinical and Experimental Immunology, 149(3), 543–552. https://doi.org/10.1111/j.1365-2249.2007.03444.x
  71. Uziel, Y., Gorodnitski, N., Mukamel, M., Padeh, S., Brik, R., Barash, J., Mevorach, D., Berkun, Y., Tauber, T., Press, J., Harel, L., Navon, P., Rubenstein, M., Naparstek, Y., & Hashkes, P. J. (2007). Outcome of a national Israeli cohort of pediatric systemic lupus erythematosus. Lupus, 16(2), 142–146. https://doi.org/10.1177/0961203306075385
  72. Schwartz, N., Shoenfeld, Y., Barzilai, O., Cervera, R., Font, J., Blank, M., Yacobi, S., Patlas, N., Cohen, A., Mevorach, D., & Ornoy, A. (2007). Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: Studies on sera from women with SLE/PAPS. Lupus, 16(2), 110–120. https://doi.org/10.1177/0961203306075741
  73. Tassiulas, I., Park-Min, K.-H., Hu, Y., Kellerman, L., Mevorach, D., & Ivashkiv, L. B. (2007). Apoptotic Cells Inhibit LPS-Induced Cytokine and Chemokine Production and IFN Responses in Macrophages. Human Immunology, 68(3), 156–164. https://doi.org/10.1016/j.humimm.2006.12.008
  74. Krispin, A., Bledi, Y., Atallah, M., Trahtemberg, U., Verbovetski, I., Nahari, E., Zelig, O., Linial, M., & Mevorach, D. (2006). Apoptotic cell thrombospondin-1 and heparin-binding domain lead to dendritic-cell phagocytic and tolerizing states. Blood, 108(10), 3580–3589. https://doi.org/10.1182/blood-2006-03-013334
  75. Fanne, R. A., Khamaisi, M., Mevorach, D., Leitersdorf, E., Berkman, N., Laxer, U., & Maly, B. (2006). Spontaneous rupture of lung echinococcal cyst causing anaphylactic shock and respiratory distress syndrome. Thorax, 61(6), 550. https://doi.org/10.1136/thx.2005.051441
  76. Benhamron, S., Nechushtan, H., Verbovetski, I., Krispin, A., Abboud-Jarrous, G., Zcharia, E., Edovitsky, E., Nahari, E., Peretz, T., Vlodavsky, I., & Mevorach, D. (2006). Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells. Journal of Immunology, 176(11), 6417–6424. https://doi.org/10.4049/jimmunol.176.11.6417
  77. Rami, A. F., Barkan, D., Mevorach, D., Leitersdorf, E., & Caraco, Y. (2006). Clozapine-induced systemic lupus erythematosus. Annals of Pharmacotherapy, 40(5), 983–985. https://doi.org/10.1345/aph.1G552
  78. Enk, C. D., Jacob-Hirsch, J., Gal, H., Verbovetski, I., Amariglio, N., Mevorach, D., Ingber, A., Givol, D., Rechavi, G., & Hochberg, M. (2006). The UVB-induced gene expression profile of human epidermis in vivo is different from that of cultured keratinocytes. Oncogene, 25(18), 2601–2614. https://doi.org/10.1038/sj.onc.1209292
  79. Arnon, T. I., Achdout, H., Levi, O., Markel, G., Saleh, N., Katz, G., Gazit, R., Gonen-Gross, T., Hanna, J., Nahari, E., Porgador, A., Honigman, A., Plachter, B., Mevorach, D., Wolf, D. G., & Mandelboim, O. (2005). Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nature Immunology, 6(5), 515–523. https://doi.org/10.1038/ni1190
  80. Ablin, J., Verbovetski, I., Trahtemberg, U., Metzger, S., & Mevorach, D. (2005). Quinidine and procainamide inhibit murine macrophage uptake of apoptotic and necrotic cells: A novel contributing mechanism of drug-induced-lupus. Apoptosis, 10(5), 1009–1018. https://doi.org/10.1007/s10495-005-1189-4
  81. Beyth, S., Borovsky, Z., Mevorach, D., Liebergall, M., Gazit, Z., Aslan, H., Galun, E., & Rachmilewitz, J. (2005). Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood, 105(5), 2214–2219. https://doi.org/10.1182/blood-2004-07-2921
  82. Rein, A. J. J. T., Mevorach, D., Perles, Z., Shovali, A., Elchalal, U., Wahren-Herlenius, M., & Sonesson, S.-E. (2005). Fetal first-degree heart block, or where to set the confidence limit: Comment on the article by Sonesson et al [4] (multiple letters). Arthritis and Rheumatism, 52(1), 366. https://doi.org/10.1002/art.20738
  83. Berkun, Y., Levartovsky, D., Rubinow, A., Orbach, H., Aamar, S., Grenader, T., Abou Atta, I., Mevorach, D., Friedman, G., & Ben-Yehuda, A. (2004). Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Annals of the Rheumatic Diseases, 63(10), 1227–1231. https://doi.org/10.1136/ard.2003.016337
  84. Szalat, A., Krasilnikov, I., Bloch, A., Meir, K., Rubinger, D., & Mevorach, D. (2004). Acute renal failure and interstitial nephritis in a patient treated with rofecoxib: Case report and review of the literature. Arthritis Care and Research, 51(4), 670–673. https://doi.org/10.1002/art.20543
  85. Mevorach, D. (2004). The role of death-associated molecular patterns in the pathogenesis of systemic lupus erythematosus. Rheumatic Disease Clinics of North America, 30(3), 487–504. https://doi.org/10.1016/j.rdc.2004.04.011
  86. Elazary, A. S., Lador, N., Shauer, A., Meir, K., Pollak, A., Wolf, D. G., Raz, I., Leitersdorf, E., & Mevorach, D. (2004). Tongue necrosis and pericarditis. Lancet, 363(9413), 948. https://doi.org/10.1016/S0140-6736(04)15790-5
  87. Shoshan, Y., & Mevorach, D. (2004). Accelerated autoimmune disease in MRL/MpJ-Fas1pr but not in MRL/MpJ following immunization with high load of syngeneic late apoptotic cells. Autoimmunity, 37(2), 103–109. https://doi.org/10.1080/08916930410001666622
  88. Hanna, J., Gonen-Gross, T., Fitchett, J., Rowe, T., Daniels, M., Arnon, T. I., Gazit, R., Joseph, A., Schjetne, K. W., Steinle, A., Porgador, A., Mevorach, D., Goldman-Wohl, D., Yagel, S., LaBarre, M. J., Buckner, J. H., & Mandelboim, O. (2004). Novel APC-like properties of human NK cells directly regulate T cell activation. Journal of Clinical Investigation, 114(11), 1612–1623. https://doi.org/10.1172/JCI22787
  89. Berkun, Y., Elami, A., Meir, K., Mevorach, D., & Naparstek, Y. (2004). Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery. Journal of Thoracic and Cardiovascular Surgery, 127(2), 414–420. https://doi.org/10.1016/j.jtcvs.2003.07.016
  90. Mevorach, D. (2003). Apoptosis: Death is part of life. Harefuah, 142(12), 832-833+878. https://www.scopus.com/inward/record.uri?eid=2-s2.0-0348219414&partnerID=40&md5=40f878fbf1e72b40ebf1bdf7fc8f4882
  91. Mevorach, D. (2003). Systemic lupus erythematosus and apoptosis: A question of balance. Clinical Reviews in Allergy and Immunology, 25(1), 49–59. https://doi.org/10.1385/CRIAI:25:1:49
  92. Mevorach, D. (2003). Dendritic cells. Modern Aspects of Immunobiology, 3(1), 16. https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749326884&partnerID=40&md5=a63d2dc25c214e5ce136ba6e6c78f1ce
  93. Verbovetski, I., Bychkov, H., Trahtemberg, U., Shapira, I., Hareuveni, M., Ben-Tal, O., Kutikov, I., Gill, O., & Mevorach, D. (2002). Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. Journal of Experimental Medicine, 196(12), 1553–1561. https://doi.org/10.1084/jem.20020263
  94. Mevorach, D. (2002). Apoptosis. Parabola, 27(2), 50–52. https://www.scopus.com/inward/record.uri?eid=2-s2.0-60950459466&partnerID=40&md5=53d2883bebf1a9667c2a9236f470bcd3
  95. Mevorach, D., & Naparstek, Y. (2001). The enigma of antigen selection and antigen recognition in systemic lupus erythematosus. Israel Medical Association Journal, 3(11), 841–842. https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035696869&partnerID=40&md5=937b67714b16e68da815631a4966c806
  96. Shoshan, Y., Shapira, I., Toubi, E., Frolkis, I., Yaron, M., & Mevorach, D. (2001). Accelerated Fas-mediated apoptosis of monocytes and maturing macrophages from patients with systemic lupus erythematosus: Relevance to in vitro impairment of interaction with iC3b-opsonized apoptotic cells. Journal of Immunology, 167(10), 5963–5969. https://doi.org/10.4049/jimmunol.167.10.5963
  97. Fishelson, Z., Attali, G., & Mevorach, D. (2001). Complement and apoptosis. Molecular Immunology, 38(2–3), 207–219. https://doi.org/10.1016/S0161-5890(01)00055-4
  98. Mevorach, D. (2000). Opsonization of apoptotic cells: Implications for uptake and autoimmunity. In Annals of the New York Academy of Sciences (Vol. 926, pp. 226–235). New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2000.tb05615.x
  99. Mevorach, D. (1999). The immune response to apoptotic cells. In Annals of the New York Academy of Sciences (Vol. 887, pp. 191–198). New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1999.tb07933.x
  100. Mevorach, D., Brezis, M., Ben Yishai, F., Sadeh, T., Shouval, D., & Eliakim, R. (1999). Increased risk of exposure to hepatitis B infection among butchers sharing knives. American Journal of Medicine, 106(4), 479–480. https://doi.org/10.1016/S0002-9343(99)00042-X
  101. Mevorach, D., Mascarenhas, J. O., Gershov, D., & Elkon, K. B. (1998). Complement-dependent clearance of apoptotic cells by human macrophages. Journal of Experimental Medicine, 188(12), 2313–2320. https://doi.org/10.1084/jem.188.12.2313
  102. Mevorach, D., Zhou, J. L., Song, X., & Elkon, K. B. (1998). Systemic exposure to irradiated apoptotic cells induces autoantibody production. Journal of Experimental Medicine, 188(2), 387–392. https://doi.org/10.1084/jem.188.2.387
  103. Niska, M., Mevorach, D., Elishoov, O., & Mattan, Y. (1998). The rheumatoid foot. Harefuah, 135(1–2), 66–69. https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032105826&partnerID=40&md5=d5c4ad70324c8012289953b3b16e5f40
  104. Alosachie, I. J., Terryberry, J. W., Mevorach, D., Chapman, Y., Lorber, M., Torre, D., Youinou, P., Peter, J. B., & Shoenfeld, Y. (1998). Central nervous system (CNS) involvement in SLE: The diagnostic role of antibodies to neuronal antigens. Clinical Reviews in Allergy and Immunology, 16(3), 275–284. https://doi.org/10.1007/BF02737637
  105. Ablin, J., Mevorach, D., & Eliakim, R. (1997). Brucellosis and the gastrointestinal tract: The odd couple. Journal of Clinical Gastroenterology, 24(1), 25–29. https://doi.org/10.1097/00004836-199701000-00005
  106. Georgescu, L., Mevorach, D., Arnett, F. C., Reveille, J. D., & Elkon, K. B. (1997). Anti-P antibodies and neuropsychiatric lupus erythematosus. In Annals of the New York Academy of Sciences (Vol. 823, pp. 263–269). Blackwell Publishing Inc. https://doi.org/10.1111/j.1749-6632.1997.tb48399.x
  107. Halkin, A., Jaffe, R., Mevorach, D., & Bursztyn, M. (1997). Thoracic complications following snake envenomization. American Journal of Medicine, 102(6), 585–587. https://doi.org/10.1016/S0002-9343(97)89438-7
  108. Levy, G., Maselovitz, S., & Mevorach, D. (1996). Rheumatic manifestations of transplant recipients. Harefuah, 130(8), 546–548. https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030584956&partnerID=40&md5=c006a801863a963074befd5b29900800
  109. Mevorach, D., Goldberg, Y., Gomori, J. M., & Rachmilewitz, D. (1996). Antiphospholipid syndrome manifested by ischemic stroke in a patient with Crohn’s disease. Journal of Clinical Gastroenterology, 22(2), 141–143. https://doi.org/10.1097/00004836-199603000-00015
  110. Mevorach, D., & Elkon, K. (1996). Neuropsychiatric lupus: Getting beyond the barrier of the brain. Lupus, 5(3), 173–174. https://doi.org/10.1177/096120339600500301
  111. Halkin, A., Lossos, I. S., & Mevorach, D. (1996). HMG-CoA reductase inhibitor-induced impotence [2]. Annals of Pharmacotherapy, 30(2), 192. https://doi.org/10.1177/106002809603000218
  112. Ablin, J., Symon, Z., & Mevorach, D. (1996). Sacral herpes-zoster infection presenting as sciatic pain. Journal of Clinical Rheumatology, 2(3), 167–168. https://doi.org/10.1097/00124743-199606000-00012
  113. Perrot, S., Job-Deslandre, C., Mevorach, D., Desplaces, N., Ziza, J.-M., & Menkes, C.-J. (1996). Seven cases of chronic recurrent multifocal osteomyelitis or pediatric SAPHO syndrome. Journal of Orthopaedic Rheumatology, 9(3), 123–127. https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029856838&partnerID=40&md5=c2616fd0edc047ff1908a94962c84cf1
  114. Mevorach, D. (1995). Management of gout-reply. Rheumatology, 34(5), 482. https://doi.org/10.1093/rheumatology/34.5.482
  115. Mevorach, D., & Heyman, S. N. (1995). Pain in the marriage. New England Journal of Medicine, 332(1), 48–50. https://doi.org/10.1056/NEJM199501053320109
  116. Moses, A. E., Mevorach, D., Rahav, G., Sacks, T., Simhon, A., & Shapiro, M. (1995). Group a streptococcus bacteremia at the hadassah medical center in Jerusalem. Clinical Infectious Diseases, 20(5), 1393–1395. https://doi.org/10.1093/clinids/20.5.1393
  117. Tishler, M., Alosachie, I., Chapman, Y., Korcyn, A., Lorber, M., Mevorach, D., Tane, D., Barka, N., Lin, H.-C., Alarcon-Segovia, D., Youinou, P., Peter, J. B., & Shoenfeld, Y. (1995). Anti-neuronal antibodies in antiphospholipid syndrome with central nervous system involvement: The difference from systemic lupus erythematosus. Lupus, 4(2), 145–147. https://doi.org/10.1177/096120339500400212
  118. Beeri, R., Golan, G., Newman, D., Steiner, I., Mevorach, D., & Brezis, M. (1995). Transverse myelitis heralding hepatitis A. Journal of Clinical Gastroenterology, 20(3), 262–263. https://doi.org/10.1097/00004836-199504000-00025
  119. Mevorach, D., Perrot, S., Laoussadi, S., Hughes, G. R., Menkes, C. J., Buchanan, N. M., & Khamashta, M. (1995). Appearance of systemic lupus erythematosus after thymectomy: Four case reports and review of the literature. Lupus, 4(1), 33–37. https://doi.org/10.1177/096120339500400108
  120. Golan, G., Beeri, R., & Mevorach, D. (1994). Henoch-schönlein purpura-like disease representing a flare of behçet’s disease. Rheumatology, 33(12), 1198–1199. https://doi.org/10.1093/rheumatology/33.12.1198-a
  121. Mevorach, D., & Menkes, C. J. (1994). Osteoarthritis and chondroprotection. Israel Journal of Medical Sciences, 30(12), 928–931. https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028607601&partnerID=40&md5=0f77a98f202eb87ca9981a406c395123
  122. Mevorach, D., Raz, E., & Steiner, I. (1994). Evidence for Intrathecal Synthesis of Autoantibodies in Systemic Lupus Erythematosus with Neurological Involvement. Lupus, 3(2), 117–121. https://doi.org/10.1177/096120339400300211
  123. Carmeli, Y., Mevorach, D., Kaminski, N., & Raz, E. (1994). Regression of Kaposi’s sarcoma after intravenous immunoglobulin treatment for polymyositis. Cancer, 73(11), 2859–2861. https://doi.org/10.1002/1097-0142(19940601)73:11<2859::AID-CNCR2820731132>3.0.CO;2-P
  124. Halon, D. A., Mevorach, D., Rodeanu, M., & Lewis, B. S. (1994). Improved criteria for localization of coronary artery disease from the exercise electrocardiogram. Cardiology, 84(4–5), 331–338. https://doi.org/10.1159/000176420
  125. River, Y., Averbuch-Heller, L., Weinberger, M., Meiner, Z., Mevorach, D., Schlesinger, I., & Argov, Z. (1994). Antibiotic induced meningitis. Journal of Neurology Neurosurgery and Psychiatry, 57(6), 705–708. https://doi.org/10.1136/jnnp.57.6.705
  126. Mevorach, D., Carmeli, Y., & Rachmilewitz, D. (1993). Genetics of inflammatory bowel diseases. Harefuah, 125(7–8), 222–224. https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027679631&partnerID=40&md5=57d143afd94575165764bd1ac4fa9d35
  127. Mevorach, D., Raz, E., Shalev, O., Steiner, I., & Ben‐Chetrit, E. (1993). Complete heart block and seizures in an adult with systemic lupus erythematosus: A possible pathophysiologic role for anti‐SS‐A/Ro and anti‐SS‐B/La autoantibodies. Arthritis & Rheumatism, 36(2), 259–262. https://doi.org/10.1002/art.1780360219
  128. Cohen, O., Mevorach, D., Ackerman, Z., & Oren, R. (1993). Thrombocytopenic purpura as a manifestation of acute hepatitis A. Journal of Clinical Gastroenterology, 17(2), 166–167. https://doi.org/10.1097/00004836-199309000-00016
  129. Mevorach, D., Lossos, I. S., & Oren, R. (1993). Cefuroxime-induced fever. Annals of Pharmacotherapy, 27(7–8), 881–882. https://doi.org/10.1177/106002809302700712
  130. Lossos, I. S., Mevorach, D., & Oren, R. (1992). Thiethylperazine treatment of gastroparesis diabeticorum [2]. Annals of Pharmacotherapy, 26(7–8), 1016. https://doi.org/10.1177/106002809202600734
  131. Mevorach, D., Leibowitz, G., Brezis, M., & Raz, E. (1992). Induction of remission in a patient with Takayasu’s arteritis by low dose pulses of methotrexate. Annals of the Rheumatic Diseases, 51(7), 904–905. https://doi.org/10.1136/ard.51.7.904
  132. Mevorach, D. (1992). Adverse effects of atropine sulfate autoinjection [3]. Annals of Pharmacotherapy, 26(4), 564. https://doi.org/10.1177/106002809202600423
  133. Mevorach, D., Eliakim, R., & Brezis, M. (1992). Hepatitis B - An occupational risk for butchers? [9]. Annals of Internal Medicine, 116(5), 428. https://doi.org/10.7326/0003-4819-116-5-428_1
  134. Heyman, S. N., Mevorach, D., & Ghanem, J. (1991). Hypertensive crisis from chronic intoxication with nasal decongestant and cough medications. DICP, Annals of Pharmacotherapy, 25(10), 1068–1070. https://doi.org/10.1177/106002809102501007